What Happened?
Cambridge, Massachusetts-based Blueprint Medicines Appointed Jennifer Shevlin as Sr Director, HR Business Partner
Date of management change: March 14, 2019
Cambridge, Massachusetts-based Blueprint Medicines Appointed Jennifer Shevlin as Sr Director, HR Business Partner
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Jennifer Shevlin is Sr Director, HR Business Partner at Blueprint Medicines. Previously, Jennifer held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Mardell Stephanie, Foreman Louis, DeJesus Liza, Webb Seema, Iyer Veda, Orantes Frederick, Erceg Mark, Burt David, Wagner Chris, May Karen, Taylor Croy
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.